Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by alainmange
Group name PlateformePP2I
Item Type Journal Article
Title Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks
Creator Ribeyre et al.
Author Cyril Ribeyre
Author Ralph Zellweger
Author Nicole Bec
Author Christian Larroque
Author Massimo Lopes
Author Angelos Constantinou
Abstract During transcription and DNA replication, the DNA template is overwound ahead of RNA and DNA polymerases and relaxed by DNA topoisomerases. Inhibitors of topoisomerases are potent anti-cancer agents. Camptothecin traps topoisomerase I on DNA and exerts preferential cytotoxicity toward cancer cells by way of its interference with the progression of replication forks. Starting with an unbiased proteomic analysis, we find that the chromatin remodeling complex BAZ1B-SMARCA5 accumulates near replication forks in camptothecin-exposed cells. We report that BAZ1B associates with topoisomerase I and facilitates its access to replication forks. Single-molecule analyses of replication structures show that BAZ1B contributes to replication interference by camptothecin. A lack of BAZ1B confers increased cellular tolerance of camptothecin. These findings reveal BAZ1B as a key facilitator of topoisomerase I function during DNA replication that affects the response of cancer cells to topoisomerase I inhibitors.
Publication Cell Reports
Volume 15
Issue 2
Pages 300-309
Date Apr 12, 2016
Journal Abbr Cell Rep
Language eng
DOI 10.1016/j.celrep.2016.03.027
ISSN 2211-1247
Library Catalog PubMed
Extra PMID: 27050524
Tags Adenosine Triphosphatases, author, Camptothecin, Chromatin Assembly and Disassembly, Chromosomal Proteins, Non-Histone, DNA, DNA Replication, DNA Topoisomerases, Type I, HeLa Cells, Humans, Male, original, pp2i, Topoisomerase I Inhibitors, Transcription Factors, Transcription, Genetic
Date Added 2019/06/04 - 17:34:02
Date Modified 2020/01/14 - 10:26:06


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés